As an alternative to the FDA-approved branded and marketed products, where appropriate, a physician or health care provider may prescribe a compounded drug, which is prepared by a state-licensed compounding pharmacy partner. Although compounded drugs are permitted to be prescribed under federal law, they are not FDA- approved and do not undergo safety, effectiveness, or manufacturing review. Zepbound and Wegovy are FDA-approved for weightloss. Ozempic is FDA-approved for type 2 diabetes treatment, but may be prescribed as an offlabel for weight loss at a healthcare provider's discretion. Nomida is NOT a compounding pharmacy.